Read twice and referred to the Committee on Finance.
The bill directs the CMS Administrator to issue a clarification within 60 days that implanted active middle ear hearing devices are prosthetics and therefore not subject to Medicare's hearing aid exclusion under section 1862(a)(7) of the Social Security Act. It adopts the prosthetic definition from 42 C.F.R. §414.202 (or successor regulation).
Beneficiary access versus federal spending obligations
Relative to its intended legislative type, this bill is a narrowly focused administrative directive that clearly states its purpose and integrates with existing law, but it provides limited implementation detail beyond a named actor and a 60-day deadline.
The bill directs the CMS Administrator to issue a clarification within 60 days that implanted active middle ear hearing devices are prosthetics and therefore not subject to Medicare's hearing aid exclusion under section 1862(a)(7) of the Social Security Act.
It adopts the prosthetic definition from 42 C.F.R. §414.202 (or successor regulation).
Low controversy, narrow administrative change increases likelihood; possible hurdles include scheduling and any CBO cost concerns.
Relative to its intended legislative type, this bill is a narrowly focused administrative directive that clearly states its purpose and integrates with existing law, but it provides limited implementation detail beyond a named actor and a 60-day deadline.
Beneficiary access versus federal spending obligations
These are examples from the analysis, not a ranked list of the most-affected groups.
Beneficiary access versus federal spending obligations
Likely supportive because the bill expands Medicare access to implanted middle ear devices for people with hearing loss.
It frames the devices as prosthetics, removing an administrative barrier to coverage and improving disability accommodation.
Some implementation and cost details are uncertain and would matter for full evaluation.
Cautiously favorable: the bill is narrowly tailored to clarify coverage status and remove an apparent anomaly in Medicare policy.
Supporters would value the limited scope and timeliness (60 days), while concerns focus on cost, administrative clarity, and downstream payment mechanics.
The net fiscal and operational impacts are plausible but uncertain without CMS specifics.
Likely skeptical because the bill directs federal bureaucracy to expand what Medicare must consider eligible, with potential cost increases.
Even though narrowly focused, conservatives will view it as another expansion of entitlement coverage and prefer more fiscal analysis before changing coverage rules.
Some may accept targeted fixes if budgetary impact is negligible.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Low controversy, narrow administrative change increases likelihood; possible hurdles include scheduling and any CBO cost concerns.
The bill has not accumulated any surfaced votes yet.
Beneficiary access versus federal spending obligations
Low controversy, narrow administrative change increases likelihood; possible hurdles include scheduling and any CBO cost concerns.
Relative to its intended legislative type, this bill is a narrowly focused administrative directive that clearly states its purpose and integrates with existing law, but it provides limited implementation detail beyond…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.